title: Premenopausal oopherectomy versus CMF chemotherapy in stage II breast carcinoma. The International Breast Cancer Study Group (IBCSG)
authors.forename: R D
authors.initials: RD
authors.lastname: Gelber
authors.forename: A
authors.initials: A
authors.lastname: Goldhirsch
authors.forename: M
authors.initials: M
authors.lastname: Castiglione
authors.forename: C M
authors.initials: CM
authors.lastname: Rudenstram
authors.forename: J
authors.initials: J
authors.lastname: Collins
authors.forename: H J
authors.initials: HJ
authors.lastname: Senn
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage; D010052:Ovariectomy; D011239:Prednisolone / Q000008:administration & dosage
chemical_list: D003520:Cyclophosphamide; D011239:Prednisolone; D005472:Fluorouracil; D008727:Methotrexate